Author:
Wang Chiuhui Mary,Whiting Amy Heagle,Rath Ana,Anido Roberta,Ardigò Diego,Baynam Gareth,Dawkins Hugh,Hamosh Ada,Le Cam Yann,Malherbe Helen,Molster Caron M.,Monaco Lucia,Padilla Carmencita D.,Pariser Anne R.,Robinson Peter N.,Rodwell Charlotte,Schaefer Franz,Weber Stefanie,Macchia Flaminia
Abstract
AbstractImproving health and social equity for persons living with a rare disease (PLWRD) is increasingly recognized as a global policy priority. However, there is currently no international alignment on how to define and describe rare diseases. A global reference is needed to establish a mutual understanding to inform a wide range of stakeholders for actions. A multi-stakeholder, global panel of rare disease experts, came together and developed an Operational Description of Rare Diseases. This reference describes which diseases are considered rare, how many persons are affected and why the rare disease population demands specific attention. The operational description of rare diseases is framed in two parts: a core definition of rare diseases, complemented by a descriptive framework of rare diseases. The core definition includes parameters that permit the identification of which diseases are considered rare, and how many persons are affected. The descriptive framework elaborates on the impact and burden of rare diseases on patients, their caregivers and families, healthcare systems, and society overall. The Operational Description of Rare Diseases establishes a common point of reference for decision-makers across the world who strive to understand and address the unmet needs of persons living with a rare disease. Adoption of this reference is essential to improving the visibility of rare conditions in health systems across the world. Greater recognition of the burden of rare diseases will motivate new actions and policies to address the unmet needs of the rare disease community.
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. UN General Assembly (74th sess. 2019–2020) High-Level Plenary Meeting on Universal Health. Political Declaration of the High-Level Plenary Meeting on Universal Health Coverage: resolution / adopted by the General Assembly, A/RES/74/2.
2. UN General Assembly (76th sess. 2021–2022). Addressing the challenges of persons living with a rare disease and their families: resolution / adopted by the General Assembly, A/RES/76/132.
3. Haendel M, Vasilevsky N, Unni D, Bologa C, Harris N, Rehm H, et al. How many rare diseases are there? Nat Rev Drug Discov. 2020;19(2):77–8.
4. Chan AYL, Chan VKY, Olsson S, Fan M, Jit M, Gong M, et al. Access and Unmet needs of Orphan drugs in 194 countries and 6 areas: A Global Policy Review with Content Analysis. Value Health J Int Soc Pharmacoeconomics Outcomes Res. 2020;23(12):1580–91.
5. Nguengang Wakap S, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V, et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet. 2020;28(2):165–73.